Immunotherapy of multiple sclerosis: where are we? Where should we go?

doi:10.1038/ni0901-785

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Immunotherapy of multiple sclerosis: where are we? Where should we go?

Nature immunology - 1 Sept 2001

Martin R, Stürzebecher C S, McFarland H F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmunity
Share to Forecasting
Share to Interferon-beta
Share to Models, Immunological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis

Share to Self Tolerance

Share to T-Lymphocytes

Share to Tumor Necrosis Factor-alpha

Source

Open in PubMed

Identifiers

PMID: 11526386
DOI: 10.1038/ni0901-785

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy of multiple sclerosis: where are we? Where should we go?PMID 11526386Read ↗

Multiple sclerosis: from immunogenetics to immunotherapy.Semantic proximity Read ↗

Immunopathology of multiple sclerosis.Semantic proximity Read ↗

IMMUNOLOGY OF MULTIPLE SCLEROSISSemantic proximity Read ↗

Which immune cells matter? The immunopathogenesis of multiple sclerosis.Semantic proximity Read ↗

Immunopathogenesis of multiple sclerosisSemantic proximity Read ↗

The immunology of multiple sclerosis.Semantic proximity Read ↗

Targeted Therapy of Multiple Sclerosis: a Case for Antigen-specific TregsSemantic proximity Read ↗

Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?Semantic proximity Read ↗

Immunology of multiple sclerosis.Semantic proximity Read ↗

Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis.Semantic proximity Read ↗

An update on multiple sclerosis.Semantic proximity Read ↗

Multiple sclerosis: a practical overview for clinicians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.